Johnson Johnson Profile

138.89
USD 0.16  0.12%
75%
67%

Acquisition by Scodari Joseph C of 109723 shares of Johnson Johnson subject to Rule 16b-3

Johnson Johnson insider trading alert for grant of employee stock option (right to buy) by Scodari Joseph C, Executive Committee Member, on October 17, 2018. This event was filed by Johnson Johnson with SEC on 2007-02-15. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Johnson Johnson Summary

Johnson & Johnson are known for their many different products. Odds are if you search your bathroom you will find multiple products made by this company. Solid and sound, the company has been upgraded by Wells Fargo, which is positive news for price movement. As well as that, the company has acquired the company Actelion, which operates in the biotech industry. [more]
Johnson Johnson (JNJ) is traded on BATS Exchange in USA. It is located in New Jersey U.S.A and employs 134,000 people. Johnson Johnson is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with total capitalization of 373.04 B. Johnson Johnson runs under Healthcare sector within Drug Manufacturers - Major industry. This company has 2.68 B outstanding shares of which 13.37 M shares are currently shorted by investors with about 2.14 days to cover shorted positions. JOHNSON AND JOHNS has about 18.14 B in cash with 17.97 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.76.
Check Johnson Johnson Probability Of Bankruptcy

Ownership Allocation (%)

Johnson Johnson Target Price Odds Analysis

Odds Below 138.89HorizonTargetOdds Above 138.89
54.30%30 days 138.89 45.06%
Based on normal probability distribution, the odds of Johnson Johnson to move above current price in 30 days from now is about 45.06% (This Johnson Johnson probability density function shows the probability of Johnson Johnson Stock to fall within a particular range of prices over 30 days) .

Johnson Johnson Top Holders

Johnson Johnson Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Bank Of MontrealCommon Shares7.1 M978.9 M
SwedbankCommon Shares3.8 M524 M
View Johnson Johnson Diagnostics

Johnson Johnson Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Gross Profit    

Johnson Johnson Key Fundamentals

Johnson Johnson Against Markets

Johnson Johnson Current Ratings

Johnson Johnson 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
9 
Equity ratings for Johnson Johnson are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Johnson Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Johnson Johnson was founded in 1885 and is based in New Brunswick, New Jersey. Johnson Johnson operates under Drug Manufacturers - Major classification in USA and is traded on BATS Exchange. It employs 134000 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Johnson Johnson SEC Filings
Johnson Johnson SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameJohnson Johnson
ChairmanAlex GorskyView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 4 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Drug Manufacturers - Major
InstrumentUSA Stock View All
RegionNorth America
LocationNew Jersey U.S.A
Business AddressOne Johnson & Johnson Plaza
Foreign Associates
ExchangeBATS Exchange
CIK Number0000200406
ISINUS4781601046
CUSIP478160104
SectorHealthcare
IndustryDrug Manufacturers - Major
BenchmarkDOW
Websitewww.jnj.com
Phone732 524 0400
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterSeptember 30, 2018
Last Fiscal Year EndDecember 31, 2017
Date Short InterestSeptember 28, 2018

Johnson Johnson Directors

Johnson Johnson Corporate Directors

William Perez Independent Director
Mary Coleman Independent Director
Mary Beckerle Director
Please also check Risk vs Return Analysis. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Search macroaxis.com